Imara Lands $31,000,000 Series A Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7a6a6b33-d31b-4c6f-8166-b62bdb4a0786 - Date
4/15/2016 - Company Name
Imara - Mailing Address
1555 Adams Menlo Park, CA 94025 USA - Company Description
Imara Corporation’s (formerly Lion Cells) mission is to provide superior energy storage solutions and accelerate the adoption of alternative U.S.- based green energy sources. - Website
Undisclosed
- Transaction Type
Venture Equity - Transaction Amount
$31,000,000 - Transaction Round
Series A - Proceeds Purposes
The funds will allow Imara to develop IMR-687, a disease-modifying therapeutic discovered by H. Lundbeck A/S and selected specifically for the treatment of sickle cell disease and other hemoglobinopathies. Lundbeck granted Imara an exclusive worldwide license and will receive certain milestone payments and royalties on sales as well as minority ownership in Imara. - M&A Terms
- Venture Investor
New Enterprise Associates - Venture Investor
Pfizer Venture Investments - Venture Investor
Lundbeckfond Ventures - Venture Investor
Bay City Capital - Venture Investor
Alexandria Venture Investments
